<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 4 Issue 4</issue_number>
<issue_period>2013 (October - December)</issue_period>
<title>PREVALENCE AND ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESCHERICHIA COLI CAUSING URINARY TRACT INFECTION </title>
<abstract>Urinary tract infection (UTI) is extremely common worldwide and numbers of patients are presenting to general practice and inpatient department. Gram negative bacteria are commonly involved in causing UTI.  lessThan i greaterThan Escherichia coli  lessThan /i greaterThan is found to be the most common causative agent of UTI. Prudent and rational use of antimicrobial is possible by forming local, national and global wide antibiogram. This study is done to find out the prevalence and antimicrobial susceptibility pattern of  lessThan i greaterThan E.coli  lessThan /i greaterThan causing urinary tract infection in tertiary care hospital, Bhopal. Total 1450 urine samples were collected and tested bacteriologically using standard procedures. Antimicrobial susceptibility testing was done by disk diffusion method described by Kirby-Bauer (1961). Culture positivity of urine samples was found to be 29 %.The most common pathogens were lessThan i greaterThan  E.coli lessThan /i greaterThan  (62%) followed by  lessThan i greaterThan Klebsiella ( lessThan /i greaterThan   lessThan i greaterThan 15.4 %), Enterobacter (6.9%), Pseudomonas (5.7%), Staphylococci aureus lessThan /i greaterThan   lessThan i greaterThan (5.7%)  lessThan /i greaterThan and others  lessThan i greaterThan (4.3%) lessThan /i greaterThan .  lessThan i greaterThan E.coli lessThan /i greaterThan  was found to be most sensitive to imipenem followed by polymyxin-B, nitrofurantoin, gatifloxacin, colistin, doxycycline, amikacin and Gentamycin.</abstract>
<authors>ASATI RAKESH KUMAR  AND SADAWARTE KALPANA</authors>
<keywords>UTI, E.coli, antibiotic susceptibility testing, antimicrobial resistance.

</keywords>
<pages>927-936</pages>
</article>
</Journal>
